SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 927,548 shares at $6.15 ($5.8M) on 2025-11-24, disclosed to the SEC on 2025-11-26.
Scheduled sale ($5.8M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.15 | 227,803 | $1.4M | 24.1% |
| 2 | $6.15 | 227,803 | $1.4M | 24.1% |
| 3 | $6.38 | 235,971 | $1.5M | 25.9% |
| 4 | $6.38 | 235,971 | $1.5M | 25.9% |
| Total | $6.27 avg | 927,548 | $5.8M | 100% |
| Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |
| VIR | SELL | 2025-10-07 | $5.8M | — | Filing → |